Investigation Overview
An investigation on behalf of investors of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) shares over potential securities laws violations by Amneal Pharmaceuticals, Inc., formerly Impax Laboratories Inc, and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchaser...
You must register (for free) or login to view the entire investigation.